Cite

HARVARD Citation

    Pecorelli, A. et al. (2017). Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. Liver international. pp. 423-433. [Online]. 
  
Back to record